Secondary amyloidosis in Crohn's disease: treatment with tumour necrosis factor inhibitor

Gut. 2006 Feb;55(2):294-5. doi: 10.1136/gut.2005.082057.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Amyloidosis / drug therapy*
  • Antibodies, Monoclonal / therapeutic use*
  • Crohn Disease / drug therapy*
  • Humans
  • Infliximab
  • Male
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Tumor Necrosis Factor-alpha
  • Infliximab